No Detail Found!

Development of DNA vaccine(s) against Mycobacterium specific genes and prime boost with BCG

Author(s)
Aeman Jilani The Islamia University of Bahawalpur,Biotechnology and Bioinformatics,Pakistan
Mirza Imran Shahzad The Islamia University of Bahawalpur,Biotechnology and Bioinformatics,Pakistan
Muhammad Mohsin Zaman The Islamia University of Bahawalpur,Biotechnology and Bioinformatics,Pakistan
Areeba Yousaf The Islamia University of Bahawalpur,Biotechnology and Bioinformatics,Pakistan
Gildardo Rivera Laboratorio de Biotecnología Farmacéutica, Centro de Biotecnología Genómica, Instituto Politécnico Nacional,,México
Abstract
Tuberculosis (TB), the white plague of Europe is still uncontrolled and fatal in many parts of the world including Pakistan. It is a major cause of morbidity and mortality in human and domestic animals in Pakistan. No new vaccine in the last hundred years has been developed except for a few encouraging results from recombinant and DNA vaccines in the past two decades. Five Mycobacterium specific genes (Rv0379, Rv3914, Rv3006, Rv0432+SP, and Rv0432-SP) were selected to develop DNA vaccine(s). All the constructs were tested on mice using both naked DNA and primeboost methodologies. Forty-five BALB/c mice were divided into three main groups; DNA vaccine group, BCG Prime boost group, and Control group. Post-vaccine (PV) and post-challenge (PC) immune responses were confirmed through cytokine ELISA and qRT PCR. IFN-? was additionally checked in plasma as well. Based on cytokine ELISA PC immune responses showed significant differences in TNF-a levels for both naked DNA vaccine groups (Rv0379, Rv3006, and Rv0432-SP) and BCG primed Rv3914 group in comparison to the BCG control group (p<0.05). Based on qRT PCR, IL-6, TNF-a, IFN-?, and IL-1ß showed no significant difference among all the vaccines and BCG control groups (CT range 25- 30). IFN-? levels in plasma were analyzed PC; two vaccines Rv3006/LppZ and BCG primed Rv0432/SodC-SP (highest mean value 1360.35 pg/ml) have shown significant results (cutoff value 21pg/ml) at 63 days. All the vaccine construct(s) alone or in combination have significant therapeutic effects in comparison to BCG and negative control groups.
Publication Details
Page(s) 1-8
Published Journal: Asian Journal of Agriculture and Biology, Volume: 3, Issue: 0, Year: 2024

Request the full text from PASTIC

Keywords
Bacille Calmette-Guérin (BCG), Mycobacterium tuberculosis, Interleukin-6, Interleukin-1beta, DNA vaccine, Interferon-gamma, Tumor necrosis factoralpha
References
Boni FG,Hamdi I,Koundi LM,Shrestha K,Xie J .2022 .Cytokine storm in tuberculosis and IL-6 involvement. Infect Genet Evol, 97 : 105166.
Cavalcanti YVN,Brelaz MCA,Neves JKDAL,Ferraz JC,Pereira VRA .2012 .Role of TNFAlpha, IFN-Gamma, and IL-10 in the Development of Pulmonary Tuberculosis. Pulm.Med, 745483 : .
Cooper AM,Dalton DK,Stewart TA,Griffin JP,Russell DG,Orme IM .1993 .Disseminated tuberculosis in interferon gamma gene-disrupted mice. JEM, 178 : 2243-2247.
Dalman MR,Deeter A,Nimishakavi G,Duan ZH .2012 .Fold change and p-value cutoffs significantly alter microarray interpretations. BMC Bioinform, 13 : S11.
Domingo-Gonzalez R,Prince O,Cooper A,Khader SA .2016 .Cytokines and Chemokines in Mycobacterium tuberculosis Infection. Microbiol Spectr, : 0018-2016.
Flynn JL .2004 .Immunology of tuberculosis and implications in vaccine development. Tuberculosis (Edinb), 84 : 93-101.
Flynn JL,Chan J,Triebold KJ,Dalton DK,Stewart TA,Bloom BR .1993 .An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. JEM, 178 : 2249-2254.
.2021 .Licence: CC BY-NCSA 3.0 IGO.. Global tuberculosis report 2021, : .
Ha S,Jeon BY,Kim S,Kim D,Song M,Sung Y,Cho SN .2003 .Therapeutic effect of DNA vaccines combined with chemotherapy in a latent infection model after aerosol infection of mice with Mycobacterium tuberculosis. Gene Ther, 10 : 1592-1599.
Kellar KL,Gehrke J,Weis SE,Mahmutovic-Mayhew A,Davila B,Zajdowicz MJ,Scarborough R,Lobue PA,Lardizabal AA,Daley CL .2011 .Multiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigens. PLoS One, 6 : e26545.
Liang-liang L,Kuan-hui L,Shi-hui X,Ting L,Guang- Z,Almutairi MH,Zahid M,Gondal MA,Wu Mehmood K,Y Mehmood K,Mathiasen VD,Andersen PH,Johansen IS,Lillebaek T,Wejse C .2020 .Clinical features of tuberculous lymphadenitis in a low-incidence country. Int J Infect Dis, 98 : 366-371.
Mbuh TP,Ane-Anyangwe I,Adeline W,Thumamo Pokam BD,Meriki HD,Mbacham WF .2019 .Bacteriologically confirmed extra pulmonary tuberculosis and treatment outcome of patients consulted and treated under program conditions in the littoral region of Cameroon. BMC Pulm Med, 19 : 018-077.
Romero-Adrian TB,Leal-Montiel J,Fernández G,Valecillo A .2015 .Role of cytokines and other factors involved in the Mycobacterium tuberculosis infection. World J Immunol, 5 : 16-50.
Russell Sambrook J,DW Sambrook J .2006 .1): pdb. CSH Protoc, 10 : .
Terracciano E,Amadori F,Zaratti L,Franco E .2020 .Tuberculosis: an ever present disease but difficult to prevent. Ig Sanita Pubbl, 76 : 59-66.
Xin P,Siliang Z,Jialin C,Bin Z,Boju P,Zhonglei P,Ying W,Ying W,Yi Z,Wei F .2014 .Screening novel diagnostic marker of Mycobacterium tuberculosis. Afr. J. Microbiol. Res, 8 : 776-782.
Yang QY,Zhang YT,Xiao JN,Liang YS,Ji P,Wang SJ,Wang Y,Chen Y,Hadizadeh Tasbiti A,Ghanei M,Shokrgozar M,Mahdian R,Fateh A,Siadat S,Vaziri F,Niknami S,Bahrmand A .2015 .Protein profiling and analysis of drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis by native polyacrylamide gel electrophoresis and mass spectrometry. Vaccine Res, 2 : 81-85.
Yu D,Hu X,Cai H .2008 .Efficient tuberculosis treatment in mice using chemotherapy and immunotherapy with the combined DNA vaccine encoding Ag85B. and MPT-83. Gene Ther, 15 : 652-659.
0

Citations

0

Downloads

15

Views